| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Medical Officer | Chief Medical Officer
1 company
Romulus K Brazzell last filed a Form 4 in October 2025, as See Remarks at KALA. Romulus K Brazzell's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Romulus K Brazzell's trades have earned a strong insider score of 77/100 across 13 rated trades. Over a 12-month horizon, 76.9% of those trades were profitable, with an average 12-month return of +44.3%.
At the last filing, the largest reported position was 35,952 shares of KALA. The KALA filings lean toward selling, a net 90,013 shares.
Romulus K Brazzell has 25 Form 4 filings on record from July 2017 to October 2025, all as Kala Bio (KALA), 2017–2025.
The 47 reported transactions were 13 open-market sales, 10 option or other derivative awards, 9 dispositions back to the company and 8 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 13 sales worth about $191K.
The largest open-market sale was 46,748 shares of KALA at an average $0.83 on October 22, 2025, about $39K. Twelve months later KALA was down 100%.
None of the 7 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from October 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | KALA Kala Bio, Inc. | See Remarks | Sell | 46,748 | $0.83 | $38,800.84 | -56.5% | -26.7% | -99.5% | |
| Jun 24, 2025 | KALA Kala Bio, Inc. | See Remarks | Sell | 5,251 | $4.01 | $21,056.51 | -6.0% | +363.8% | -25.0% | |
| Jun 3, 2025 | KALA Kala Bio, Inc. | See Remarks | Sell | 3,687 | $3.74 | $13,789.38 | -4.0% | +198.0% | -45.5% | |
| Jan 6, 2025 | KALA Kala Bio, Inc. | See Remarks | Sell | 2,446 | $7.63 | $18,662.98 | -2.6% | -50.3% | -91.3% | |
| Jun 26, 2024 | KALA Kala Bio, Inc. | See Remarks | Sell | 5,489 | $4.75 | $26,072.75 | -6.1% | +20.0% | +14.2% | |
| May 31, 2024 | KALA Kala Bio, Inc. | See Remarks | Sell | 2,002 | $6.09 | $12,192.18 | -2.2% | -12.4% | -44.6% | |
| Jan 4, 2024 | KALA Kala Bio, Inc. | See Remarks | Sell | 1,617 | $6.74 | $10,898.58 | -1.7% | +11.1% | +13.3% | |
| Jan 4, 2023 | KALA Kala Bio, Inc. | See Remarks | Sell | 73 | $28.53 | $2,082.69 | -0.4% | -67.0% | -83.4% | |
| Oct 26, 2022 | KALA Kala Bio, Inc. | See Remarks | Sell | 261 | $6.51 | $1,699.11 | -4.3% | +168.5% | +18.0% | |
| Jun 27, 2022 | KALA Kala Bio, Inc. | See Remarks | Sell | 3,144 | $0.37 | $1,163.28 | -1.1% | -37.2% | -11.6% |